Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinyebaidu is a Traditional Chinese Medicine (TCM) compound formulated as granules, primarily used for clearing heat and detoxifying the body. It is composed of several herbal ingredients, including honeysuckle, Isatis leaf, dandelion, and Houttuynia cordata. The drug is indicated for the treatment of various upper respiratory tract infections, influenza, viral pneumonia, and acute bacterial infections. It gained significant attention for its use in the prevention and treatment of novel coronavirus pneumonia (COVID-19) and was included in relevant guidelines in China. Jinyebaidu is known for its antibacterial, antiviral, anti-endotoxin, anti-inflammatory, and immune-modulating properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jinyebaidu.